Episode
E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)
- Published
- Nov 12, 2025
- Duration seconds
- 1143
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/the-evidence-based-rheumatology-podcast-1130175/episodes/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-evidence-based-rheumatology-podcast-1130175/e128-nerandomilast-for-autoimmune-ild-fibroneer-ild.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out! Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643